Vera Vavrova Lab/VIAL, Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06, Prague, Czech Republic.
Department of Biotechnology, University of Chemistry and Technology, Prague, Czech Republic.
Sci Rep. 2022 May 24;12(1):8704. doi: 10.1038/s41598-022-12760-x.
Approximately one third of children with steroid-resistant nephrotic syndrome (SRNS) carry pathogenic variants in one of the many associated genes. The WT1 gene coding for the WT1 transcription factor is among the most frequently affected genes. Cases from the Czech national SRNS database were sequenced for exons 8 and 9 of the WT1 gene. Eight distinct exonic WT1 variants in nine children were found. Three children presented with isolated SRNS, while the other six manifested with additional features. To analyze the impact of WT1 genetic variants, wild type and mutant WT1 proteins were prepared and the DNA-binding affinity of these proteins to the target EGR1 sequence was measured by microscale thermophoresis. Three WT1 mutants showed significantly decreased DNA-binding affinity (p.Arg439Pro, p.His450Arg and p.Arg463Ter), another three mutants showed significantly increased binding affinity (p.Gln447Pro, p.Asp469Asn and p.His474Arg), and the two remaining mutants (p.Cys433Tyr and p.Arg467Trp) showed no change of DNA-binding affinity. The protein products of WT1 pathogenic variants had variable DNA-binding affinity, and no clear correlation with the clinical symptoms of the patients. Further research is needed to clarify the mechanisms of action of the distinct WT1 mutants; this could potentially lead to individualized treatment of a so far unfavourable disease.
约三分之一的激素耐药性肾病综合征(SRNS)患儿携带许多相关基因中的一个致病性变异。编码 WT1 转录因子的 WT1 基因是最常受影响的基因之一。对捷克国家 SRNS 数据库中的病例进行了 WT1 基因的外显子 8 和 9 测序。在 9 名儿童中发现了 8 个不同的 WT1 外显子变异体。其中 3 名患儿表现为单纯性 SRNS,而其余 6 名患儿则表现出其他特征。为了分析 WT1 基因突变的影响,制备了野生型和突变型 WT1 蛋白,并通过微尺度热泳法测量这些蛋白与靶 EGR1 序列的 DNA 结合亲和力。3 个 WT1 突变体显示 DNA 结合亲和力显著降低(p.Arg439Pro、p.His450Arg 和 p.Arg463Ter),另外 3 个突变体显示 DNA 结合亲和力显著增加(p.Gln447Pro、p.Asp469Asn 和 p.His474Arg),而另外两个突变体(p.Cys433Tyr 和 p.Arg467Trp)则没有改变 DNA 结合亲和力。WT1 致病性变异体的蛋白产物具有可变的 DNA 结合亲和力,与患者的临床症状无明显相关性。需要进一步研究来阐明不同 WT1 突变体的作用机制;这可能为目前尚无有效治疗方法的疾病提供个体化治疗的可能性。